Results found that OC-2 gene silencing in MCF-7 cells led to cell apoptosis and suppressed tumor growth, suggesting the potential value of OC-2 in serving as the candidate target for breast cancer antitumor therapy. This evidence concerns the gene ONECUT2 and breast carcinoma.